Page 83 - Read Online

cells in the cerebrospinal fluid of breast cancer patients with central for neoplastic meningitis: detecting disease, identifying patient risk, and
nervous system metastases. Oncotarget 2011;2:752-60. determining benefit of treatment. Semin Oncol 2009;36:S35-45.
4. Bonadio W. Pediatric lumbar puncture and cerebrospinal fluid 22. Enting RH. Leptomeningeal neoplasia: epidemiology, clinical
analysis. J Emerg Med 2014;46:141-50. presentation, CSF analysis and diagnostic imaging. Cancer Treat Res
5. Brinker T, Stopa E, Morrison J, Klinge P. A new look at cerebrospinal 2005;125:17-30.
fluid circulation. Fluids Barriers CNS 2014;11:10. 23. Ahluwalia MS, Wallace PK, Peereboom DM. Flow cytometry as a
6. Johanson CE, Duncan JA, 3rd, Klinge PM, Brinker T, Stopa EG, diagnostic tool in lymphomatous or leukemic meningitis: ready for
Silverberg GD. Multiplicity of cerebrospinal fluid functions: New prime time? Cancer 2012;118:1747-53.
challenges in health and disease. Cerebrospinal Fluid Res 2008;5:10. 24. Glantz MJ, Cole BF, Glantz LK, Cobb J, Mills P, Lekos A, Walters
7. Machida A, Ohkubo T, Yokota T. Circulating microRNAs in the BC, Recht LD. Cerebrospinal fluid cytology in patients with cancer.
cerebrospinal fluid of patients with brain diseases. Methods Mol Biol Cancer 1998;82:733-9.
2013;1024:203-9. 25. Strik H, Luthe H, Nagel I, Ehrlich B, Bahr M. Automated
8. Shen F, Zhang Y, Yao Y, Hua W, Zhang HS, Wu JS, Zhong P, Zhou LF. cerebrospinal fluid cytology: limitations and reasonable applications.
Proteomic analysis of cerebrospinal fluid: toward the identification of Anal Quant Cytol Histol 2005;27:167-73.
biomarkers for gliomas. Neurosurg Rev 2014;37:367-80; discussion 26. Gomes HR. Cerebrospinal fluid approach on neuro-oncology. Arq
80. Neuropsiquiatr 2013;71:677-80.
9. Chamberlain M, Soffietti R, Raizer J, Ruda R, Brandsma D, Boogerd 27. Kim JH, Lee SK, Yoo YC, Park NH, Park DB, Yoo JS, An HJ, Park
W, Taillibert S, Groves MD, Le Rhun E, Junck L, van den Bent YM, Cho KG. Proteome analysis of human cerebrospinal fluid as a
M, Wen PY, Jaeckle KA. Leptomeningeal metastasis: a Response diagnostic biomarker in patients with meningioma. Med Sci Monit
Assessment in Neuro-Oncology critical review of endpoints and 2011;18:BR450-60.
response criteria of published randomized clinical trials. Neuro 28. Okamoto H, Li J, Vortmeyer AO, Jaffe H, Lee YS, Glasker S, Sohn
Oncol 2014;16:1176-85. TS, Zeng W, Ikejiri B, Proescholdt MA, Mayer C, Weil RJ, Oldfield
10. Chamberlain MC. Leptomeningeal metastasis. Curr Opin Oncol EH, Zhuang Z. Comparative proteomic profiles of meningioma
2010;22:627-35. subtypes. Cancer Res 2006;66:10199-204.
11. Patel AS, Allen JE, Dicker DT, Peters KL, Sheehan JM, Glantz MJ, 29. Vankalakunti M, Vasishta RK, Das Radotra B, Khosla VK. MIB-1
El-Deiry WS. Identification and enumeration of circulating tumor immunolabeling: a valuable marker in prediction of benign recurring
cells in the cerebrospinal fluid of breast cancer patients with central meningiomas. Neuropathology 2007;27:407-12.
nervous system metastases. Oncotarget 2014;2:752-60. 30. Wulfkuhle JD, Paweletz CP, Steeg PS, Petricoin EF, 3rd, Liotta L.
12. Gajjar A, Fouladi M, Walter AW, Thompson SJ, Reardon DA, Proteomic approaches to the diagnosis, treatment, and monitoring of
Merchant TE, Jenkins JJ, Liu A, Boyett JM, Kun LE, Heideman RL. cancer. Adv Exp Med Biol 2003;532:59-68.
Comparison of lumbar and shunt cerebrospinal fluid specimens for 31. Kalinina J, Peng J, Ritchie JC, Van Meir EG. Proteomics of gliomas:
cytologic detection of leptomeningeal disease in pediatric patients initial biomarker discovery and evolution of technology. Neuro
with brain tumors. J Clin Oncol 1999;17:1825-8. Oncol 2011;13:926-42.
13. Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer 32. Gollapalli K, Ray S, Srivastava R, Renu D, Singh P, Dhali S, Bajpai
Treat Rev 1999;25:103-19. Dikshit J, Srikanth R, Moiyadi A, Srivastava S. Investigation of
14. Weston CL, Glantz MJ, Connor JR. Detection of cancer cells in the serum proteome alterations in human glioblastoma multiforme.
cerebrospinal fluid: current methods and future directions. Fluids Proteomics 2012;12:2378-90.
Barriers CNS 2011;8:14. 33. Iwadate Y, Sakaida T, Hiwasa T, Nagai Y, Ishikura H, Takiguchi M,
15. Singh G, Mathur SR, Iyer VK, Jain D. Cytopathology of neoplastic Yamaura A. Molecular classification and survival prediction in human
meningitis: A series of 66 cases from a tertiary care center. gliomas based on proteome analysis. Cancer Res 2004;64:2496-501.
Cytojournal 2013;10:13. 34. Batabyal SK, Ghosh B, Sengupta S, Ghosh SN, Chatterjee R.
16. Fouladi M, Gajjar A, Boyett JM, Walter AW, Thompson SJ, Cerebrospinal fluid and serum carcinoembryonic antigen in brain
Merchant TE, Jenkins JJ, Langston JW, Liu A, Kun LE, Heideman tumors. Neoplasma 2003;50:377-9.
RL. Comparison of CSF cytology and spinal magnetic resonance 35. Moldrich G, Lange P, Strik H. Carcinoembryonic antigen in the CSF
imaging in the detection of leptomeningeal disease in pediatric of cancer patients--the value of intrathecal synthesis and correlation
medulloblastoma or primitive neuroectodermal tumor. J Clin Oncol with IgA-diffusion dynamics. Acta Neurol Belg 2010;110:314-20.
1999;17:3234-7. 36. Nakagawa H, Kubo S, Murasawa A, Nakajima S, Nakajima Y,
17. Terterov S, Krieger MD, Bowen I, McComb JG. Evaluation Izumoto S, Hayakawa T. Measurements of CSF biochemical tumor
of intracranial cerebrospinal fluid cytology in staging pediatric markers in patients with meningeal carcinomatosis. No Shinkei Geka
medulloblastomas, supratentorial primitive neuroectodermal tumors, 1991;19:1135-41. (in Japanese)
and ependymomas. J Neurosurg Pediatr 2010;6:131-6. 37. Nakagawa H, Kubo S, Murasawa A, Nakajima S, Nakajima Y,
18. Nayak L, Fleisher M, Gonzalez-Espinoza R, Lin O, Panageas K, Izumoto S, Hayakawa T. Measurements of CSF biochemical tumor
Reiner A, Liu CM, Deangelis LM, Omuro A. Rare cell capture markers in patients with meningeal carcinomatosis and brain tumors.
technology for the diagnosis of leptomeningeal metastasis in solid J Neurooncol 1992;12:111-20.
tumors. Neurology 2013;80:1598-605; discussion 603. 38. Wang P, Piao Y, Zhang X, Li W, Hao X. The concentration of CYFRA
19. Pan Z, Yang G, Wang Y, He H, Pang X, Gao Y, Shi W, Li Y, Dong L, 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators
Song Y. Thinprep plus Papanicolaou stain method is more sensitive for diagnosis of meningeal carcinomatosis of lung cancer. Cancer
than cytospin-coupled Wright Giems stain method in cerebrospinal Biomark 2013;13:123-30.
fluid cytology for diagnosis of leptomeningeal metastasis from solid 39. Khwaja FW, Nolen JD, Mendrinos SE, Lewis MM, Olson JJ, Pohl J,
tumors. PLoS One 2015;10:e0122016. Van Meir EG, Ritchie JC, Brat DJ. Proteomic analysis of cerebrospinal
20. Bach F, Bjerregaard B, Soletormos G, Bach FW, Horn T. Diagnostic fluid discriminates malignant and nonmalignant disease of the central
value of cerebrospinal fluid cytology in comparison with tumor nervous system and identifies specific protein markers. Proteomics
marker activity in central nervous system metastases secondary to 2006;6:6277-87.
breast cancer. Cancer 1993;72:2376-82. 40. Samuel N, Remke M, Rutka JT, Raught B, Malkin D. Proteomic
21. Chamberlain MC, Glantz M, Groves MD, Wilson WH. Diagnostic tools analyses of CSF aimed at biomarker development for pediatric brain

184
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ May 18, 2016 ¦